So-Young International Inc (SY)
1.071
+0.04
(+3.97%)
USD |
NASDAQ |
Jun 20, 16:00
1.06
-0.01
(-1.03%)
After-Hours: 20:00
So-Young International Enterprise Value: -59.72M for June 18, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 18, 2024 | -59.72M |
| June 17, 2024 | -55.64M |
| June 14, 2024 | -52.06M |
| June 13, 2024 | -52.54M |
| June 12, 2024 | -46.44M |
| June 11, 2024 | -45.41M |
| June 10, 2024 | -46.43M |
| June 07, 2024 | -43.36M |
| June 06, 2024 | -43.36M |
| June 05, 2024 | -47.45M |
| June 04, 2024 | -50.52M |
| June 03, 2024 | -54.61M |
| May 31, 2024 | -56.66M |
| May 30, 2024 | -57.68M |
| May 29, 2024 | -60.75M |
| May 28, 2024 | -63.71M |
| May 24, 2024 | -58.70M |
| May 23, 2024 | -54.61M |
| May 22, 2024 | -46.43M |
| May 21, 2024 | -50.52M |
| May 20, 2024 | -47.96M |
| May 17, 2024 | -39.27M |
| May 16, 2024 | -38.25M |
| May 15, 2024 | -37.22M |
| May 14, 2024 | -35.18M |
| Date | Value |
|---|---|
| May 13, 2024 | -32.11M |
| May 10, 2024 | -30.06M |
| May 09, 2024 | -30.06M |
| May 08, 2024 | -23.93M |
| May 07, 2024 | -32.62M |
| May 06, 2024 | -33.13M |
| May 03, 2024 | -33.13M |
| May 02, 2024 | -33.13M |
| May 01, 2024 | -34.16M |
| April 30, 2024 | -32.11M |
| April 29, 2024 | -31.09M |
| April 26, 2024 | -36.71M |
| April 25, 2024 | -38.25M |
| April 24, 2024 | -40.29M |
| April 23, 2024 | -38.25M |
| April 22, 2024 | -30.06M |
| April 19, 2024 | -46.43M |
| April 18, 2024 | -42.34M |
| April 17, 2024 | -45.41M |
| April 16, 2024 | -47.96M |
| April 15, 2024 | -52.57M |
| April 12, 2024 | -45.41M |
| April 11, 2024 | -48.48M |
| April 10, 2024 | -48.48M |
| April 09, 2024 | -42.34M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-163.76M
Minimum
Oct 31 2022
1.492B
Maximum
Jun 27 2019
344.48M
Average
91.98M
Median
Enterprise Value Benchmarks
| Sinovac Biotech Ltd | -7.011B |
| CASI Pharmaceuticals Inc | 34.70M |
| Zai Lab Ltd | 1.255B |
| Adagene Inc | 29.46M |
| LakeShore Biopharma Co Ltd | 105.57M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.968M |
| Revenue (Quarterly) | 44.48M |
| Total Expenses (Quarterly) | 49.63M |
| EPS Diluted (Quarterly) | -0.029 |
| Gross Profit Margin (Quarterly) | 63.14% |
| Profit Margin (Quarterly) | -6.67% |
| Earnings Yield | 1.68% |
| Normalized Earnings Yield | 1.065 |